Author:
Xu Yuan,Fyfe Murray,Walker Liz,Cowen Laura LE
Abstract
Abstract
Background
Population size estimation is critical for planning public health programmes for injection drug users. Estimation is difficult, as these populations are considered 'hidden’ or 'hard to reach’. The currently accepted population size estimate for greater Victoria, Canada is between 1,500 and 2,000 individuals, which is dated prior to the year 2000, and is likely an underestimate.
Methods
We used three mark-recapture methods (the Lincoln-Petersen estimator, Huggins' model, and Pledger's model) to estimate population size using cross-sectional survey data collected in 2003 and 2005. Data come from a closed population with two time-ordered samples from the same source. We compare our estimates with the currently accepted estimate that is based on the registry of a Victoria needle exchange.
Results
All methods provided population size estimates that were higher than the currently accepted estimate. Huggins' method produced wider confidence intervals. Point estimates of population size from the three methods ranged from 3,329 to 3,342.
Conclusions
Our estimates will aid health authorities in planning for harm reduction programmes. Repeating the methods as further phases of I-Track data become available will ensure that the population estimates remain up to date.
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health,Public Health, Environmental and Occupational Health,Medicine (miscellaneous)
Reference27 articles.
1. Stajduhar K, Poffenroth L, Wong E, Archibald C, Sutherland D, Rekart M: Missed opportunities: injection drug use and HIV/AIDS in Victoria, Canada. Int J Drug Policy. 2004, 15: 171-181. 10.1016/j.drugpo.2004.01.001.
2. Stajduhar KI, Poffenroth L, Wong E: Missed Opportunities: Putting a Face on Injection Drug Use and HIV/AIDS in the Capital Health Region. 2002, Vancouver, BC: Centre for Health Evaluation and Outcome Sciences (CHÉOS) Scientific Monograph, Monograph 10
3. Vancouver Island Health Authority: I-Track survey: enhanced surveillance of risk behaviours and prevalence of HIV and hepatitis C among people who inject drugs.http://www.viha.ca/NR/rdonlyres/5E14E205-5398-4267-AA61-34F9D671F22B/0/Final_ITRACK_Report_Victoria_20060605.pdf,
4. Domingo-Salvany A, Hartnoll RL, Maguire A, Brugal MT, Albertin PA, Caylà JA, Casabona J, Suelves JM: Analytical considerations in the use of capture-recapture to estimate prevalence: case studies of the estimation of opiate use in the metropolitan area of Barcelona, Spain. Am J Epidemiol. 1998, 148: 732-740. 10.1093/oxfordjournals.aje.a009694.
5. Hickman M, Higgins V, Hope V, Bellis M, Tilling K, Walker A, Henry J: Injecting drug use in Brighton, Liverpool, and London: best estimates of prevalence and coverage of public health indicators. J Epidemiol Community Health. 2004, 58: 766-771. 10.1136/jech.2003.015164.
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献